Jim Beam is getting ready for summer with the unveiling of its latest flavor innovation, Jim Beam Pineapple, adding to its ...
In addition to Twist Bioscience, ARK also increased its stake in Beam Therapeutics Inc (NASDAQ:BEAM) by acquiring a combined 47,127 shares across its ARKK and ARKG ETFs, valued at $1,526,914.